See more : Shawcor Ltd. (SCL.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Doximity, Inc. (DOCS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Doximity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Shanghai Aj Group Co.,Ltd (600643.SS) Income Statement Analysis – Financial Results
- Commerce Resources Corp. (CCE.V) Income Statement Analysis – Financial Results
- Delta Manufacturing Limited (DELTAMAGNT.BO) Income Statement Analysis – Financial Results
- Aeon Metals Limited (AEOMF) Income Statement Analysis – Financial Results
- Shengda Resources Co.,Ltd. (000603.SZ) Income Statement Analysis – Financial Results
Doximity, Inc. (DOCS)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.doximity.com
About Doximity, Inc.
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 475.42M | 419.05M | 343.55M | 206.90M | 116.39M | 85.70M |
| Cost of Revenue | 50.67M | 53.49M | 39.79M | 31.20M | 14.90M | 10.89M |
| Gross Profit | 424.75M | 365.56M | 303.76M | 175.70M | 101.49M | 74.81M |
| Gross Profit Ratio | 89.34% | 87.24% | 88.42% | 84.92% | 87.20% | 87.29% |
| Research & Development | 81.98M | 80.19M | 62.35M | 43.87M | 32.44M | 27.50M |
| General & Administrative | 37.83M | 36.75M | 35.75M | 16.49M | 7.44M | 7.34M |
| Selling & Marketing | 133.13M | 123.52M | 92.13M | 62.03M | 39.45M | 33.05M |
| SG&A | 170.96M | 160.27M | 127.88M | 78.53M | 46.89M | 40.39M |
| Other Expenses | 0.00 | 8.05M | 469.00K | 4.17M | 1.35M | -59.00K |
| Operating Expenses | 260.88M | 240.45M | 190.23M | 122.40M | 79.33M | 67.89M |
| Cost & Expenses | 311.54M | 293.94M | 230.01M | 153.59M | 94.23M | 78.77M |
| Interest Income | 21.66M | 9.29M | 2.15M | 301.00K | 1.46M | 1.07M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 10.27M | 12.31M | 6.20M | 6.14M | 2.90M | 551.00K |
| EBITDA | 182.08M | 125.11M | 113.54M | 63.90M | 26.41M | 7.47M |
| EBITDA Ratio | 38.30% | 32.31% | 34.52% | 27.55% | 19.82% | 8.72% |
| Operating Income | 163.88M | 125.11M | 113.54M | 53.30M | 22.16M | 6.92M |
| Operating Income Ratio | 34.47% | 29.86% | 33.05% | 25.76% | 19.04% | 8.08% |
| Total Other Income/Expenses | 21.32M | 8.05M | 469.00K | 4.47M | 1.35M | 1.01M |
| Income Before Tax | 185.20M | 133.16M | 114.01M | 57.77M | 23.51M | 7.93M |
| Income Before Tax Ratio | 38.96% | 31.78% | 33.18% | 27.92% | 20.20% | 9.25% |
| Income Tax Expense | 37.62M | 20.34M | -40.78M | 7.56M | -6.22M | 98.00K |
| Net Income | 147.58M | 112.82M | 154.78M | 50.21M | 29.74M | 7.83M |
| Net Income Ratio | 31.04% | 26.92% | 45.05% | 24.27% | 25.55% | 9.14% |
| EPS | 0.78 | 0.58 | 0.81 | 0.12 | 0.06 | 0.05 |
| EPS Diluted | 0.72 | 0.53 | 0.70 | 0.12 | 0.06 | 0.05 |
| Weighted Avg Shares Out | 190.17M | 193.18M | 163.65M | 181.70M | 181.70M | 171.42M |
| Weighted Avg Shares Out (Dil) | 205.73M | 213.43M | 191.21M | 181.70M | 181.70M | 171.42M |
Doximity: Strong Fundamentals And Growth Potential Makes It Attractive
Buy 5 High-Flying Health & Fitness Stocks of 2024 With More Upside
Doximity initiated with a Neutral at Mizuho
Are Medical Stocks Lagging Doximity (DOCS) This Year?
Dr Martens redemption arc will be ‘multi-year event'
Dr Martens shares booted higher despite swinging to a loss
Dr Martens delivers double-digit sales decline and jumbo pre-tax loss
Dr Martens set to unveil loss as all eyes on outlook in results
3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
Source: https://incomestatements.info
Category: Stock Reports